According to an abstract released on November 13th, Calithera’s (NASDAQ:CALA) Triple-Negative-Breast-Cancer appears to show a very positive signal, especially among African-American Women. However, …
Billionaire Israel “Izzy” Englander, who helmed his fortune from humble, Polish immigrant beginnings took a chance on two giants that have played with …
Acorda Therapeutics Inc (NASDAQ:ACOR) shareholders are spooked right now after the drug maker confirmed yesterday that enrollment in two long-term safety trials for …
Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) has enticing clinical potential that has caught the eyes of more than one bull who have sounded off on …
Shares of biopharma Synergy Pharmaceuticals (NASDAQ:SGYP) are now almost half the price one month ago following a controversial equity offering. With prices so …
Teva Pharmaceutical (NYSE:TEVA) has a few loose ends untied, from generics pressures to brand drug launches and pipelines that still need to prove …
Roku Inc (NASDAQ:ROKU) had just had quite the earnings party, with investors sending shares skyrocketing November 9th on back of an impressive first …
Immunomedics, Inc. (NASDAQ:IMMU) left investors worried about its cancer asset IMMU-132 after revealing an abstract at yesterday’s annual San Antonio Breast Cancer Symposium …
Valeant Pharmaceuticals (NYSE:VRX) has attracted a great deal of positive Street buzz after last Tuesday’s posted third quarter beat. BMO analyst Gary Nachman …